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ABSTRACT: Prochlorosins make up a class of secondary
metabolites produced by strains of Prochlorococcus, single-cell,
planktonic marine cyanobacteria. These polycyclic peptides contain
lanthionine and methyllanthionine residues that result in thioether
cross-links. In Prochlorococcus MIT9313, a single enzyme, ProcM,
catalyzes the posttranslational modiﬁcation of 29 linear peptide
substrates to generate a library of highly diverse cyclic peptides. To
investigate the catalytic promiscuity of ProcM, we chose four
prochlorosins previously demonstrated to be produced by the
organism for detailed structural characterization. Nuclear magnetic resonance studies allowed unambiguous assignment of the
ring topologies, demonstrating a high degree of topological diversity. The stereochemistry of the lanthionine and
methyllanthionine residues was determined by gas chromatography and mass spectrometry for seven prochlorosins. All
methyllanthionines had the (2S,3S,6R) conﬁguration, and the lanthionines had the (2S,6R) conﬁguration, irrespective of the
direction of cyclization, ring size, or ring topology. These ﬁndings indicate that most, if not all, of the rings in prochlorosins are
formed enzymatically by ProcM lanthionine synthetase and not by a nonenzymatic process as previously suggested.
L
antipeptides are ribosomally synthesized and posttransla-
tionally modiﬁed peptides, characterized by the thioether
amino acids lanthionine (Lan) and methyllanthionine
(MeLan).
1,2 Lantipeptides with antimicrobial activities are
called lantibiotics.
3 In lantipeptide-producing organisms, the
precursor peptides, termed LanAs, are expressed with an N-
terminal leader sequence and a C-terminal core peptide (e.g.,
Figure 1A). The core peptide is modiﬁed by a dehydratase,
generating dehydroalanine (Dha) and dehydrobutyrine (Dhb)
from Ser and Thr, respectively (Figure 1B). Subsequently,
intramolecular additions of the thiols of Cys to the Dha and
Dhb residues generate the thioether cross-links (Figure 1B). In
class II lantipeptides, these two sequential modiﬁcations are
conducted by one enzyme, generically called LanM.
4 The
leader peptide is removed in the ﬁnal step of lantipeptide
biosynthesis to form the mature products.
5
Prochlorosins (Pcns) make up a group of lantipeptides
produced by Prochlorococcus.
6 In Prochlorococcus MIT9313, 29
diﬀerent peptide substrates are modiﬁed by a single
promiscuous enzyme, ProcM, forming the characteristic
thioether rings.
6 The 29 precursor peptides have highly
conserved leader peptides but highly diverse core peptides
where the posttranslational modiﬁcations occur (Figure 1A).
This class of lanthionine-containing peptides is of interest not
only because of the remarkable promiscuity of the enzyme but
also because the organisms carrying these genes are
cyanobacteria accounting for as much as half of the chlorophyll
in the tropical and subtropical oceans with a lifestyle very
diﬀerent from those of other known lantipeptide-producing
organisms.
7 They are single-cell organisms living in oligotrophic
environments at very dilute concentrations, making it debatable
whether prochlorosins serve as antimicrobial defenses like most
other known lantipeptides.
8
Analysis of the Global Oceanic Survey showed that the genes
for production of these lanthionine-containing peptides are
widespread.
6,9 Their transcription levels respond to nitrogen
starvation, suggesting that the prochlorosins are functional.
6
However, it remains unclear why the organisms produce this
class of secondary metabolites and what their functions are. To
address these questions as well as understand the remarkable
substrate tolerance of ProcM, it is important to know the
chemical structures of prochlorosins, including their ring
topologies and the stereochemical conﬁgurations of their Lan
and MeLan residues.
Preliminary structural characterization of several prochlor-
osins has been achieved by tandem mass spectrometry (MS).
6
The presence of a thioether cross-link prohibits fragmentation
of the peptide in the ring, and therefore, the fragmentation
pattern can be used for ring topology prediction.
4,6 However,
tandem MS encounters diﬃculties in elucidating the ring
topology for structures that contain overlapping rings. In such
cases, mutagenesis is usually employed to prevent the formation
of one or several overlapping rings such that the topology of the
remaining rings can be established using tandem MS. However,
because ProcM exhibits a very low substrate speciﬁcity under
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structures, it is possible that the ring topology of the mutants is
not that of the wild-type prochlorosins. Indeed, a single point
mutation in ProcA4.3 has been shown to change the original
ring pattern.
6 Therefore, tandem MS has its limitations for the
determination of the structures of prochlorosins, and other
complementary techniques are required. In this study, we used
nuclear magnetic resonance (NMR) spectroscopy to determine
the ring topologies of four prochlorosins (Pcn1.1, Pcn1.7,
Pcn3.3, and Pcn4.3) for which the precursor genes have been
shown to be transcribed under nitrogen starvation.
In addition to questions about the ring patterns of
prochlorosins, the stereochemical conﬁgurations of their Lan
and MeLan residues have not been determined. Lan and
MeLan residues in lantipeptides and lantibiotics for which the
stereochemistry has been determined all exhibit (2S,6R) and
(2S,3S,6R)c o n ﬁgurations, respectively.
10 Because ProcM
generates such a diversity of ring topologies, we previously
speculated that perhaps only some rings are formed enzymati-
cally, thus preorganizing the partially cyclized peptides for
nonenzymatic cyclization to generate the ﬁnal ring structures.
6
Determination of the conﬁguration of Lan and MeLan residues
in prochlorosins could potentially serve to assess whether a ring
is formed enzymatically or nonenzymatically.
To address this hypothesis, we investigated the stereo-
chemical conﬁguration of Lan and MeLan residues of seven
prochlorosins (Pcn1.1, Pcn1.7, Pcn2.8, Pcn2.11, Pcn3.2,
Pcn3.3, and Pcn4.3) by gas chromatography and MS (GC−
MS) with a chiral stationary phase and compared them with
synthetic standards.
11−13 We were able to conduct these
experiments by producing milligram quantities of the selected
prochlorosins by heterologous coexpression of the precursor
peptides with ProcM in Escherichia coli.
14
■ MATERIALS AND METHODS
General Methods. All polymerase chain reactions (PCRs)
were conducted on a C1000 thermal cycler (Bio-Rad). DNA
sequencing was performed by ACGT, Inc. Preparative high-
performance liquid chromatography (HPLC) was performed
using a Waters Delta 600 instrument equipped with appropriate
columns. Matrix-assisted laser desorption ionization time-of-
ﬂight mass spectrometry (MALDI-TOF MS) was conducted on
a Voyager-DE-STR (Applied Biosystems). Overexpression and
puriﬁcation of the modiﬁed precursor peptides were performed
using previously reported procedures.
14
Construction of pRSFDuet-1 Derivatives for Coex-
pression of ProcM and ProcAs. The genes encoding
ProcA1.1G−1E and ProcA4.3 were cloned from previously
reported vectors
6 and inserted into multiple cloning site 1 of
the pRSFDuet-1/procM-2 vector
14 using the EcoRI and NotI
restriction sites. Primer sequences are listed in Table S1 of the
Supporting Information. Negative numbers are used for amino
acids in the leader peptide counting backward from the putative
leader peptide cleavage site. The sequences of the constructed
vectors were conﬁrmed by DNA sequencing. The pRSFDuet-
1/procM-2, pRSFDuet-1/procM-2-procA3.3G−1K,
pRSFDuet-1/procM-2-procA1.7G−1R, pRSFDuet-1/procM-2-
procA2.8, pRSFDuet-1/procM-2-procA2.11G−1K, pRSFDuet-
Figure 1. Precursor peptides of the 29 prochlorosins from Prochlorococcus MIT9313 and enzymatic transformations during biosynthesis of
lantipeptides. (A) Sequence alignment of the 29 precursor peptides illustrating the high degree of conservation in their leader peptides and the high
degree of diversity in their core peptides. The four peptides investigated here are denoted with pink boxes at the left. (B) Dehydration and
cyclization reactions during the biosynthesis of lantibiotics and lantipeptides.
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and pRSFDuet-1/procM-2-procA4.3G−1E vectors were ob-
tained as reported previously.
14
Protease Cleavage and Puriﬁcation of Prochlorosin
Core Peptides. Posttranslationally modiﬁed ProcA mutants
were treated with the commercial protease GluC to remove the
leader peptides. For some peptides, additional proteases were
used to process the long leader peptides into smaller fragments,
which sometimes proved to be advantageous for puriﬁcation
(LysC for ProcA1.1G−1E and ProcA3.3G−1K and trypsin for
ProcA4.3). In such instances, the modiﬁed core peptide was not
proteolyzed even if it contained potential cleavage sites for
LysC or trypsin, presumably because the presence of
dehydrated amino acids and/or (Me)Lan residues greatly
reduced the proteolytic eﬃciency. The protease cleavage
reactions were quenched with 0.5% TFA, and the desired
products were conﬁrmed by MALDI-TOF MS and puriﬁed by
reversed phase HPLC (RP-HPLC) using a Jupiter proteo C12
column (5 μm, 90 Å, 250 mm × 10.0 mm). Solvents for RP-
HPLC were solvent A (0.1% TFA in water) and solvent B
(0.086% TFA in 80% acetonitrile and 20% water). The desired
core peptides eluted from the column between 40 and 60%
solvent B, and pure fractions were lyophilized.
NMR Spectroscopy. NMR spectra were acquired at the
NMR Facility (School of Chemical Sciences, University of
Illinois at Urbana-Champaign) on Varian INOVA 600 or 500
MHz spectrometers equipped with a 5 mm triple-resonance
(1H, 13C, 15N) triaxial gradient probe. Lyophilized peptides
were dissolved in a 90% H2O/10% D2O mixture to a ﬁnal
concentration of 5−7 mM and a pH of 3.5 to improve
solubility. NMR spectra were acquired at 20 °C for 2048 direct
and 256 of 400 indirect data points with 16 or 32 scans
depending on the peptide concentration. TOCSY
15 (mixing
time of 0.080 s), gradient double-quantum-ﬁltered COSY
(gDQCOSY),
16 and NOESY
17 spectra were acquired with
solvent suppression by presaturation or water gate pulse
sequences. The lyophilized peptides were dissolved in 100%
D2O, and NOESY spectra were acquired without exchangeable
proton signals. NOESY spectra of Pcn1.1 and -3.3 were
acquired with a mixing time of 0.20 s, while those of Pcn1.7 and
-4.3 were acquired with a mixing time of 0.40 s, which resulted
in clearer nuclear Overhauser eﬀect (NOE) signals. Spectra
were processed with NMRPipe
18 and analyzed in Sparky.
19
GC−MS Analysis. The synthesis of Lan and MeLan
standards and the preparation of samples for GC−MS analysis
were conducted following a reported procedure.
12 For Pcn1.1,
-1.7, -3.3, and -4.3, the puriﬁed modiﬁed core peptides were
used, whereas for Pcn2.8, -2.11, and -3.2, the ProcM-modiﬁed
precursor peptides with their leader sequences still attached
were used. The derivatized samples were analyzed by GC−MS
Figure 2. Water-suppressed TOCSY spectrum identifying all residues of Pcn1.7. Each vertical line indicates a spin system corresponding to an amino
acid. A water-suppressed NOESY spectrum (Figure S2 of the Supporting Information) along with the gene sequence was used to assign the residue
numbering.
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Varian CP-Chirasil-L-Val fused silica column (25 m × 0.25 mm
× 0.15 μm). Samples were dissolved in methanol and
introduced into the instrument via splitless injection at a ﬂow
rate of 1.7 or 2.0 mL/min in helium gas. The following
temperature gradient was used: 160 °C for 5 min, from 160 to
180 °C at a rate of 3 °C/min, and 180 °C for 10 min. The mass
spectrometer was operated in simultaneous scan/selected-ion
monitoring (SIM) mode, monitoring at the characteristic
fragment masses of 365 Da for Lan and 379 Da for MeLan
residues.
■ RESULTS
Coexpression of ProcAs and ProcM in E. coli. To obtain
milligram quantities of peptides required for NMR character-
ization, a heterologous coexpression system was employed
using E. coli as a host.
14,20−23 Using a pRSFDuet vector, ProcM
and His-tagged ProcAs were coexpressed and the modiﬁed
precursor peptides were puriﬁed by immobilized metal aﬃnity
chromatography (IMAC) followed by RP-HPLC. Using this
procedure, ∼80 mg of modiﬁed prochlorosins with their leader
peptides still attached could be obtained from 1 L of LB
culture. Protease cleavage sites were engineered at the −1
position to remove the leader peptides and produce the mature
core peptides. These mutant peptides were all fully processed
by ProcM except for ProcA4.3G−1R and ProcA4.3G−1E. As a
result, wild-type ProcA4.3 was used for coexpression, and the
Glu at position −6 was used as a cleavage site for
endoproteinase GluC to generate a core peptide with ﬁve
residues at its N-terminus that remained from the leader
peptide. Unlike ProcA4.3, ProcA1.7 and ProcA3.3 mutated at
position −1( G −1R and G−1K, respectively) were still
processed by ProcM to generate the fully modiﬁed products.
However, for ProcA3.3, the engineered cleavage site was close
to a dehydrated amino acid, resulting in a greatly reduced
eﬃciency of removal of the leader peptide by endoproteinase
LysC, whereas for ProcA1.7, the selected protease (trypsin)
caused cleavage in the core peptide, which greatly reduced the
yield. To obtain suﬃcient amounts of the modiﬁed core
peptides, the Glu at position −6 was also used for these two
peptides to remove most of the leader peptide with GluC
endoproteinase. MALDI-TOF mass spectra of the resulting
modiﬁed core peptides are shown in Figure S1 of the
Supporting Information.
NMR Spectral Assignments. To determine the ring
topology, the observed NMR resonances were ﬁrst assigned.
A series of one-dimensional (1D) and two-dimensional NMR
experiments were performed for this purpose. The amino acid
assignments were obtained primarily from TOCSY and
gDQCOSY spectra. The TOCSY spectrum of Pcn1.7 is
shown in Figure 2 as an example. TOCSY spectra for the
other three prochlorosins are shown in Figure S3 (Pcn1.1),
Figure S6 (Pcn3.3), and Figure S9 (Pcn4.3) of the Supporting
Information. The chemical shifts of amide protons in these
peptides in 90% H2O and 10% D2O were between 7 and 10
ppm, most of which showed good dispersion. The number of
amide protons was determined by integration of 1D 1H NMR
spectra. Each vertical line in each TOCSY spectrum
corresponds to the spin system of one amino acid, with the
amide proton resonance on the x-axis and the chemical shifts of
the side chain proton resonances on the y-axis. The N-terminal
residues have no amide resonance and hence were not
observed. The amide signals of all amino acids were observed
for each of the four prochlorosins. They were assigned to a
speciﬁc amino acid by taking into account the observed
chemical shifts and numbers of resonances of the side chain
Figure 3. Illustration of the method used to establish thioether connectivities. (A) Schematic illustration of the proton correlations used to
determine ring topologies. (B) Section of the NOESY spectrum (mixing time of 0.40 s) of Pcn1.7 in D2O showing the correlations between β
protons. (C) Section of the NOESY spectrum showing the correlations of the α protons with α and β protons across the thioether bridge. (D)
Section of the NOESY spectrum showing the correlations of the γ protons with α and β protons across the thioether bridge. In panels B−D,
correlations are assigned to rings A, B, and C of Pcn1.7 (see also Figure 4). For enlarged panels B and C, see Figures S18 and S19 of the Supporting
Information.
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TOCSY spectra. The amide proton signals of Dhb residues
always appeared as singlets in the low ﬁeld region with chemical
shifts of >9.3 ppm, and the β/γ proton signals of Dhb displayed
weak correlations to their corresponding amide protons in the
TOCSY spectra.
Assignments of each residue to a speciﬁc position in the
amino acid sequence were made on the basis of the
connectivity of dNN(i,i+1) as well as dαN(i,i+1) in the NOESY
spectra (Figure S2 for Pcn1.7, Figure S4 for Pcn1.1, Figure S7
for Pcn3.3, and Figure S10 for Pcn4.3), taking into
consideration the amino acid sequences deduced from the
procA genes.
Ring Topology Assigned by NMR Spectroscopy. In the
discussion below, the fragment of the Lan residues originating
from Ser will be designated Ala(S) and the fragment that
originates from Cys will be designated Cys (Ala and Cys are
colored red and green, respectively, in Figure 3A). Similarly, the
fragment of MeLan residues that originates from Thr will be
designated Abu(S) (for 2-aminobutyric acid), and the fragment
originating from Cys will be designated Cys. The chemical
shifts for the β protons of putative Ala(S) and Abu(S) residues
observed in the TOCSY experiments provided the ﬁrst
evidence of ring formation. Dha/Dhb residues that were
converted into thioether cross-links had chemical shifts of their
β protons of ∼3 ppm, whereas Dha/Dhb residues that were not
involved in ring formation displayed β proton chemical shifts
between 6 and 7 ppm.
Next, NOESY spectra were acquired in D2O to simplify the
spectrum and focus on the NOEs involving the Lan/MeLan
protons, which allow assignment of the ring topology
24−29
(Figure 3 for Pcn1.7, Figure S5 for Pcn1.1, Figure S8 for
Pcn3.3, and Figure S11 for Pcn4.3). A longer NOESY mixing
time of 0.40 s was used for Pcn1.7 and -4.3. Intense NOE
signals between the β protons of an Ala(S)/Abu(S) and a Cys
were taken as evidence of a cross-link between these residues
(Figure 3B). These assignments were further supported by
correlations of α protons of Ala(S)/Abu(S) with the β protons
of the Cys with which it was cross-linked, as well as correlations
between α protons of Cys residues and the β protons of
Ala(S)/Abu(S) residues (Figure 3C). In the case of MeLan, the
γ protons on the methyl groups of Abu(S) residues showed
additional correlations with the α and β protons of their partner
Cys (Figure 3D). For some prochlorosins (i.e., Pcn1.1, -3.3,
and -4.3), these latter correlations were particularly diagnostic
to conﬁrm the deduced ring structures because less signal
overlap was present in this region of the spectra (Figures S5,
S8, and S11 of the Supporting Information). Collectively, this
approach allowed assignment of all resonances to individual
residues and therefore established the topology of the rings
(Figure 4). For Pcn1.1, Pcn1.7, and Pcn3.3, the NMR
assignments agreed with the previous tandem MS data.
6 For
Pcn4.3, the NMR results in this study allowed assignment of
the second ring that was not possible by MS.
6 The NMR data
clearly show that this ring is formed from Thr8 and Cys12, and
that Ser9 remained unmodiﬁed.
We note that the additional amino acids remaining from the
leader peptides in prochlorosins 1.7, 3.3, and 4.3 showed fewer
correlation signals in the NOESY spectrum, suggesting that the
N-terminus is conformationally more ﬂexible than the modiﬁed
core peptide.
Determination of the Stereochemistry of Lan and
MeLan Residues. To determine the stereochemical conﬁg-
urations of the Lan and MeLan residues in the four
prochlorosins for which the NMR structures were determined,
the peptides were hydrolyzed in 6 M HCl, derivatized to their
corresponding pentaﬂuoropropionamide methyl esters, and
analyzed by GC−MS with a chiral stationary phase. Lan and
MeLan standards with diﬀerent stereochemical conﬁgurations
were synthesized and derivatized using previously reported
methods.
12 A Chirasil-L-Val-coated GC column was used for
analysis, and the GC trace was monitored for a characteristic
fragment of 365 Da for Lan and 379 Da for MeLan using
electron impact mass spectrometry. Figure 5 displays the GC−
MS traces for the products from Pcn1.7 as well as the Lan and
MeLan standards. As shown in Figure 5A, the derivatized
MeLan standards with DL (2S,3S,6R) and LL (2R,3R,6R)
conﬁguration were well separated, with retention times of
14.1−14.4 and 14.4−14.7 min, respectively. The derivatized
Lan standards with DD (2S,6S), DL (2S,6R), and LL (2R,6R)
conﬁgurations eluted later than the MeLan standards and were
also well separated with retention times of 18.2−18.6, 18.6−
19.0, and 19.0−19.4 min, respectively (Figure 5B). Derivatized
MeLan originating from Pcn1.7 eluted with a retention time of
14.1−14.4 min (Figure 5C), indicating that the MeLan in
Pcn1.7 has a DL conﬁguration. To further conﬁrm this result,
the derivatized DL and LL MeLan standards were co-injected
with the derivatized MeLan originating from the peptide. As
illustrated in Figure 5, the derivatized MeLan fragment from
Pcn1.7 coeluted with the DL MeLan standard (Figure 5C), but
not with the LL MeLan standard (Figure 5D). MeLan standards
with the D-allo-L (2S,3R,6R) and L-allo-L (2R,3S,6R) conﬁg-
uration were not synthesized in this study because the reported
elution times of the derivatized MeLan diastereomers on a
Chirasil-L-Val-coated GC column increase in the following
order: DL < LL < L-allo-L < D-allo-L.
12 In this work, no derivatized
MeLan residues were observed to elute after the LL standard,
ruling out the presence of MeLan residues with an L-allo-L or D-
allo-L conﬁguration. The MeLan residues present in the other
three prochlorosins were analyzed using the same procedure,
and all had the DL conﬁguration (Figure S12 for Pcn1.1, Figure
S13 for Pcn3.3, and Figure S14 for Pcn4.3).
Similarly, derivatized Lan originating from Pcn1.7 coeluted
with the Lan standard with the DL conﬁguration but not with
either the DD or LL Lan standard (Figure 5E−G). The small
shoulders on the derivatized DL-Lan peak arising from Pcn1.7
are believed to be caused by partial epimerization during HCl
hydrolysis, which has been reported previously.
30 The GC trace
Figure 4. Ring topology of four selected prochlorosins assigned by
NMR spectroscopy in this work. Arrows indicate the start of the
putative core peptide. Asterisks indicate prochlorosins containing ﬁve
more residues at their N-terminus that originate from the leader
peptides. Blue residues are the engineered cleavage sites at position −1
in the leader peptides.
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contains Lan, was more complicated. Although the derivatized
DL-Lan was still the dominant peak, an additional peak in the
GC trace accounted for ∼20% of the total Lan (Figure 6A).
The material giving rise to this peak was conﬁrmed to be
derivatized LL-Lan by co-injections (Figure S14E of the
Supporting Information). This result was in agreement with
the NMR data (1D water-suppressed spectrum shown in Figure
6B), which exhibited minor peaks with integration values
around 25% of that of the main peaks. These NMR data
demonstrate that the LL-Lan was already present in Pcn4.3
before acid hydrolysis and derivatization and was not
introduced by epimerization during HCl hydrolysis.
In addition to the prochlorosins for which the NMR
structures were determined, the stereochemistry of the Lan
and MeLan residues was determined for three other ProcA
substrates that were posttranslationally modiﬁed by ProcM in
E. coli (ProcA2.8, ProcA2.11, and ProcA3.2). The correspond-
ing prochlorosins could not be produced in suﬃcient purity
after leader peptide removal for NMR studies, but after
hydrolysis and derivatization of the resulting amino acids, GC−
MS analysis demonstrated that they contained Lan and MeLan
residues with the same conﬁg u r a t i o n sa si nt h eo t h e r
prochlorosins (Figures S15−S17 of the Supporting Informa-
tion).
■ DISCUSSION
In this study, we set out to investigate three aspects of
prochlorosin biosynthesis: whether tandem MS is reliable for
determination of ring topologies, whether suﬃcient quantities
of material can be produced such that NMR spectroscopy can
be used when MS data are inconclusive, and whether the
stereochemistries of the Lan and MeLan residues are the same
as those in other lantipeptides. To address these questions, we
ﬁrst produced larger amounts of prochlorosins by heterologous
expression in E. coli because less than 10 μg of impure products
was obtained from 20 L of culture of Prochlorococcus
MIT9313.
6 Although the peptides obtained by proteolysis
with commercial proteases contain additional amino acids at
their N-termini compared to authentic prochlorosins, for
determination of the ring topology and stereochemistry of
(Me)Lan residues, these ﬁve additional amino acids of the
leader peptide are inconsequential.
The NMR data reported here conﬁrm the ring topologies of
three prochlorosins that were previously proposed on the basis
of tandem mass spectrometry in combination with site-directed
mutagenesis. Thus, the concern that a highly promiscuous
enzyme like ProcM might process a mutant peptide diﬀerently
from a wild-type peptide appears not to be corroborated for
these compounds. Mass spectrometric approaches used in the
previous study could not answer the question of whether Thr8
or Ser9 was involved in the B-ring of Pcn4.3.
6 The NMR data
in this study show conclusively that it is Thr8 that is dehydrated
in wt ProcA4.3 and that it makes a thioether cross-link with
Cys12 (Figure 4).
Collectively, these results raise the question of why mutants
of ProcA1.7 and ProcA3.3 that were made in the previous
study
6 to deduce their ring topologies by tandem MS were
processed correctly by ProcM, as shown by the NMR data in
this study, whereas mutants of ProcA4.3 were not. Although we
cannot address this question directly, processing of ProcA4.3 by
ProcM appears to be less robust in general. First, mutations at
the −1 position in ProcA4.3 completely abolished ProcM
activity in this study, whereas ProcM fully processed mutants at
Figure 5. GC−MS traces (selected ion monitoring, SIM, at 365 Da for Lan and 379 Da for MeLan) of derivatized (Me)Lan standards and co-
injections with derivatized Lan/MeLan obtained from Pcn1.7. (A) Derivatized DL-MeLan () and LL-MeLan (---) standards. (B) Derivatized DD-
Lan (···), DL-Lan (), and LL-Lan (---) standards. (C) Hydrolyzed and derivatized amino acids from Pcn1.7 (---) and co-injected with the DL-MeLan
standard (). (D) Hydrolyzed and derivatized amino acids from Pcn1.7 (---) and co-injected with the derivatized LL-MeLan standard (). (E)
Hydrolyzed and derivatized amino acids from Pcn1.7 (---) and co-injected with the DD-Lan standard (). (F) Hydrolyzed and derivatized amino
acids from Pcn1.7 (---) and co-injected with the DL-Lan standard (). (G) Hydrolyzed and derivatized amino acids from Pcn1.7 (---) and co-
injected with the LL-Lan standard (). Lan and MeLan from Pcn1.7 used for overlays were adjusted to 70% intensity for the sake of clarity.
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whereas all Lan and MeLan residues in Pcn1.1, Pcn1.7, and
Pcn3.3 were formed in high stereochemical purity with the
same stereochemistry (DL), the Lan in Pcn4.3 was decidedly
less pure and contained ∼20% of the LL diastereomer. As shown
in Figure 4, the A-ring of Pcn4.3 contains two Gly residues
between the Dha and Cys that form this lanthionine, and
perhaps the resulting increased conformational freedom allows
enzymatic cyclization that results in protonation of the enolate
from the opposite face. Alternatively, the lower stereochemical
ﬁdelity of cyclization of this particular Lan structure could be
the result of nonenzymatic cyclization as discussed below.
The determination of the ring topologies of four diﬀerent
prochlorosins in this study demonstrates the remarkable
substrate ﬂexibility of the ProcM enzyme. Inspection of Figure
4 illustrates that the structures of the four selected
prochlorosins do not exhibit any similarity to each other or
to any other known lantibiotics/lantipeptides.
8 The rings
generated by ProcM contain very diﬀerent numbers of amino
acids, from four residues in the A-rings of Pcn1.7 and Pcn4.3 to
11 residues in the A-ring of Pcn3.3. Furthermore, the rings are
generated either from a Cys that is located N-terminally to the
dehydro amino acid with which it reacts (A-ring of Pcn 1.1 and
B-ring of Pcn3.3) or from a Cys located C-terminally of its
partner dehydro amino acid (all other rings). Finally, Pcn1.1
and -4.3 have nonoverlapping rings; Pcn1.7 has overlapping
rings, and Pcn3.3 contains a ring within a ring. Although many
lantipeptide cyclases achieve formation of diﬀerent sized rings
with diﬀerent topologies, ProcM, and presumably its many
orthologs in the world’s oceans, is unique in that it acts on so
many diﬀerent substrates.
It was this unprecedented ﬂexibility that led to a proposal
that perhaps the enzyme generates only a subset of the rings
and that the partially cyclized intermediates would have a
preorganized structure for nonenzymatic cyclization of the
remaining rings.
6 This proposal was bolstered by the previously
observed facile nonenzymatic intramolecular addition of Cys to
dehydro amino acids located N-terminal to the Cys
residue.
31−37 These model studies of nonenzymatic cyclization
showed that formation of individual small rings is often
stereoselective and results in the same stereochemistry that is
observed for enzymatic cyclization. However, for larger rings or
multiple-ring structures, nonenzymatic cyclization has been
shown to give mixtures of diastereomers and/or constitutional
isomers,
33,38,39 and cyclization involving a Cys located N-
terminally to its partner dehydro amino acid has been shown to
be nonstereoselective.
35 Therefore, in this investigation, the
stereochemistry of the Lan and MeLan structures of
prochlorosins was determined to test for nonenzymatic
cyclization. The GC−MS data clearly illustrate that the Lan
residues in prochlorosins have the (2S,6R) conﬁguration and
that the MeLan residues have the (2S,3S,6R) conﬁguration.
These conﬁgurations are the same as those found for all
lantibiotics for which the stereochemistry has been deter-
mined.
10 As discussed above, the only exception was the Lan in
Pcn4.3, which had a 4:1 ratio of DL and LL diastereomers.
Although these results do not rule out nonenzymatic
cyclization, they also do not provide support for nonenzymatic
cyclization, and on the basis of the data in this study on seven
prochlorosins with very diﬀerent ring structures, we favor a
model in which ProcM does generate all thioether cross-links.
One interesting unique aspect of ProcM and its orthologs is the
fact that on the basis of sequence alignments, its catalytic Zn2+
is liganded by three Cys residues rather than the two Cys
residues and one His residue that are found for all other LanM
and LanC lanthionine cyclases investigated thus far.
40−44 The
Zn2+ has been proposed to activate the Cys residues of the
substrate for nucleophilic attack on the dehydro amino acids.
40
Model studies of activation of thiolate nucleophiles by Zn2+
have demonstrated increased reactivity with an increased
number of thiolate ligands.
45−48 Therefore, ProcM may derive
its promiscuity in part from a highly active Zn2+ site with three
Cys ligands from ProcM and one Cys ligand from the substrate.
In summary, we report here the NMR structures of four
prochlorosins and show for seven prochlorosins that they
contain Lan and MeLan residues with the same conﬁguration
that is found in other lantibiotics and lantipeptides. These data
suggest that most, if not all, of the rings are generated by the
Figure 6. LL-Lan diastereomer in Pcn4.3 and its relative abundance.
(A) GC−MS trace of hydrolyzed and derivatized amino acids of
Pcn4.3 monitored for Lan. DD-Lan (18.2−18.6 min), DL-Lan (18.6−
19.0 min), and LL-Lan (19.0−19.4 min) eluted from the column, with
the relative peak areas indicated. (B) 1D water-suppressed NMR
spectrum of Pcn4.3. Minor peaks originate from a diﬀerent
diastereomer of Pcn4.3 containing LL-Lan as shown in panel A.
Integrations of two pairs of major and minor peaks are shown to
estimate the relative amount of the diastereomer.
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products.
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